<DOC>
	<DOC>NCT00406172</DOC>
	<brief_summary>To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.</brief_summary>
	<brief_title>Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Pseudophakic eyes with macular edema Other retinopathies</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>